Your browser doesn't support javascript.
loading
Genome instability is a consequence of transcription deficiency in patients with bone marrow failure harboring biallelic ERCC6L2 variants.
Tummala, Hemanth; Dokal, Arran D; Walne, Amanda; Ellison, Alicia; Cardoso, Shirleny; Amirthasigamanipillai, Saranha; Kirwan, Michael; Browne, Isobel; Sidhu, Jasmin K; Rajeeve, Vinothini; Rio-Machin, Ana; Seraihi, Ahad Al; Duncombe, Andrew S; Jenner, Matthew; Smith, Owen P; Enright, Helen; Norton, Alice; Aksu, Tekin; Özbek, Namik Yasar; Pontikos, Nikolas; Cutillas, Pedro; Dokal, Inderjeet; Vulliamy, Tom.
Affiliation
  • Tummala H; Genomics and Child Health, Blizard Institute, Queen Mary University of London, E1 2AT London, United Kingdom; h.tummala@qmul.ac.uk.
  • Dokal AD; Barts Cancer Institute, Queen Mary University of London, EC1M 6BQ London, United Kingdom.
  • Walne A; Genomics and Child Health, Blizard Institute, Queen Mary University of London, E1 2AT London, United Kingdom.
  • Ellison A; Genomics and Child Health, Blizard Institute, Queen Mary University of London, E1 2AT London, United Kingdom.
  • Cardoso S; Genomics and Child Health, Blizard Institute, Queen Mary University of London, E1 2AT London, United Kingdom.
  • Amirthasigamanipillai S; Genomics and Child Health, Blizard Institute, Queen Mary University of London, E1 2AT London, United Kingdom.
  • Kirwan M; Genomics and Child Health, Blizard Institute, Queen Mary University of London, E1 2AT London, United Kingdom.
  • Browne I; Genomics and Child Health, Blizard Institute, Queen Mary University of London, E1 2AT London, United Kingdom.
  • Sidhu JK; Genomics and Child Health, Blizard Institute, Queen Mary University of London, E1 2AT London, United Kingdom.
  • Rajeeve V; Barts Cancer Institute, Queen Mary University of London, EC1M 6BQ London, United Kingdom.
  • Rio-Machin A; Barts Cancer Institute, Queen Mary University of London, EC1M 6BQ London, United Kingdom.
  • Seraihi AA; Barts Cancer Institute, Queen Mary University of London, EC1M 6BQ London, United Kingdom.
  • Duncombe AS; Department of Haematology, University Hospital Southampton, SO16 6YD Southampton, United Kingdom.
  • Jenner M; Department of Haematology, University Hospital Southampton, SO16 6YD Southampton, United Kingdom.
  • Smith OP; Our Lady's Children's Hospital, Trinity College Dublin, Crumlin, Dublin 12, Ireland.
  • Enright H; Adelaide and Meath Hospital, Trinity College Medical School, Dublin 24, Ireland.
  • Norton A; Department of Clinical and Laboratory Haematology, Birmingham Children's Hospital, B4 6NH Birmingham, United Kingdom.
  • Aksu T; Pediatric Hematology and Oncology, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, University of Health Sciences, Ankara 06100, Turkey.
  • Özbek NY; Pediatric Hematology and Oncology, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, University of Health Sciences, Ankara 06100, Turkey.
  • Pontikos N; UCL Institute of Ophthalmology, University College London, EC1V 9EL London, United Kingdom.
  • Cutillas P; Barts Cancer Institute, Queen Mary University of London, EC1M 6BQ London, United Kingdom.
  • Dokal I; Genomics and Child Health, Blizard Institute, Queen Mary University of London, E1 2AT London, United Kingdom.
  • Vulliamy T; Genomics and Child Health, Blizard Institute, Queen Mary University of London, E1 2AT London, United Kingdom.
Proc Natl Acad Sci U S A ; 115(30): 7777-7782, 2018 07 24.
Article in En | MEDLINE | ID: mdl-29987015
ABSTRACT
Biallelic variants in the ERCC excision repair 6 like 2 gene (ERCC6L2) are known to cause bone marrow failure (BMF) due to defects in DNA repair and mitochondrial function. Here, we report on eight cases of BMF from five families harboring biallelic variants in ERCC6L2, two of whom present with myelodysplasia. We confirm that ERCC6L2 patients' lymphoblastoid cell lines (LCLs) are hypersensitive to DNA-damaging agents that specifically activate the transcription coupled nucleotide excision repair (TCNER) pathway. Interestingly, patients' LCLs are also hypersensitive to transcription inhibitors that interfere with RNA polymerase II (RNA Pol II) and display an abnormal delay in transcription recovery. Using affinity-based mass spectrometry we found that ERCC6L2 interacts with DNA-dependent protein kinase (DNA-PK), a regulatory component of the RNA Pol II transcription complex. Chromatin immunoprecipitation PCR studies revealed ERCC6L2 occupancy on gene bodies along with RNA Pol II and DNA-PK. Patients' LCLs fail to terminate transcript elongation accurately upon DNA damage and display a significant increase in nuclear DNA-RNA hybrids (R loops). Collectively, we conclude that ERCC6L2 is involved in regulating RNA Pol II-mediated transcription via its interaction with DNA-PK to resolve R loops and minimize transcription-associated genome instability. The inherited BMF syndrome caused by biallelic variants in ERCC6L2 can be considered as a primary transcription deficiency rather than a DNA repair defect.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription, Genetic / Bone Marrow Diseases / DNA Helicases / Genomic Instability / DNA Repair / Alleles / Genetic Diseases, Inborn Limits: Female / Humans / Male Language: En Journal: Proc Natl Acad Sci U S A Year: 2018 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription, Genetic / Bone Marrow Diseases / DNA Helicases / Genomic Instability / DNA Repair / Alleles / Genetic Diseases, Inborn Limits: Female / Humans / Male Language: En Journal: Proc Natl Acad Sci U S A Year: 2018 Type: Article